Literature DB >> 11516997

Clinical and genetic heterogeneity in nemaline myopathy--a disease of skeletal muscle thin filaments.

D Sanoudou1, A H Beggs.   

Abstract

The term nemaline myopathy (NM) encompasses a heterogeneous group of disorders of primary skeletal muscle weakness characterized by the presence of nemaline rods in muscles of affected individuals. Disease severity is variable and unpredictable, with prognosis ranging from neonatal death to almost normal motor function. Recent advances in the identification of NM disease genes demonstrate that NM is a disease of the skeletal muscle sarcomere and, in particular, of the thin filaments. These findings are starting to alter the approach that neurologists and geneticists take to diagnosing and counseling patients with NM, and could lead to insights into specific directed therapies in the future.

Entities:  

Mesh:

Year:  2001        PMID: 11516997     DOI: 10.1016/s1471-4914(01)02089-5

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  58 in total

1.  Ultrastructural changes in cardiac myocytes from Boxer dogs with arrhythmogenic right ventricular cardiomyopathy.

Authors:  Eva M Oxford; Charles G Danko; Bruce G Kornreich; Karen Maass; Shari A Hemsley; Dima Raskolnikov; Philip R Fox; Mario Delmar; N Sydney Moïse
Journal:  J Vet Cardiol       Date:  2011-06-01       Impact factor: 1.701

2.  Nemaline myopathy in the Ashkenazi Jewish population is caused by a deletion in the nebulin gene.

Authors:  Sylvia L Anderson; Josef Ekstein; Mary C Donnelly; Erin M Keefe; Nicole R Toto; Lauretta A LeVoci; Berish Y Rubin
Journal:  Hum Genet       Date:  2004-06-23       Impact factor: 4.132

Review 3.  Tropomodulins: pointed-end capping proteins that regulate actin filament architecture in diverse cell types.

Authors:  Sawako Yamashiro; David S Gokhin; Sumiko Kimura; Roberta B Nowak; Velia M Fowler
Journal:  Cytoskeleton (Hoboken)       Date:  2012-05-04

Review 4.  [Treatability of sporadic late onset nemaline myopathy].

Authors:  F Hanisch; I Schneider; T Müller; B F Romeike; G Stoltenburg; H J Holzhausen; S Zierz
Journal:  Nervenarzt       Date:  2013-08       Impact factor: 1.214

Review 5.  Muscle giants: molecular scaffolds in sarcomerogenesis.

Authors:  Aikaterini Kontrogianni-Konstantopoulos; Maegen A Ackermann; Amber L Bowman; Solomon V Yap; Robert J Bloch
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

6.  Skeletal muscle repair in a mouse model of nemaline myopathy.

Authors:  Despina Sanoudou; Mark A Corbett; Mei Han; Majid Ghoddusi; Mai-Anh T Nguyen; Nicole Vlahovich; Edna C Hardeman; Alan H Beggs
Journal:  Hum Mol Genet       Date:  2006-07-28       Impact factor: 6.150

7.  Knockin mouse model of the human CFL2 p.A35T mutation results in a unique splicing defect and severe myopathy phenotype.

Authors:  Samantha M Rosen; Mugdha Joshi; Talia Hitt; Alan H Beggs; Pankaj B Agrawal
Journal:  Hum Mol Genet       Date:  2020-07-29       Impact factor: 6.150

8.  Treatment with ActRIIB-mFc Produces Myofiber Growth and Improves Lifespan in the Acta1 H40Y Murine Model of Nemaline Myopathy.

Authors:  Jennifer Tinklenberg; Hui Meng; Lin Yang; Fujun Liu; Raymond G Hoffmann; Mahua Dasgupta; Kenneth P Allen; Alan H Beggs; Edna C Hardeman; R Scott Pearsall; Robert H Fitts; Michael W Lawlor
Journal:  Am J Pathol       Date:  2016-04-18       Impact factor: 4.307

9.  Clinical heterogeneity in Korean patients with nemaline myopathy.

Authors:  Ji-Man Hong; Seung-Min Kim; Il-Nam Sunwoo; Se-Hoon Kim; Tai-Seung Kim; Dong-Suk Shim; Young-Chul Choi
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

10.  Nebulin regulates actin filament lengths by a stabilization mechanism.

Authors:  Christopher T Pappas; Paul A Krieg; Carol C Gregorio
Journal:  J Cell Biol       Date:  2010-05-24       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.